In the Boardroom - Merck Serono

Filter

Current filters:

Merck Serono

Popular Filters

73 to 97 of 161 results

Pfizer names Albert Bourla as group president as Amy Schulman steps down

Pfizer names Albert Bourla as group president as Amy Schulman steps down

18-12-2013

Changes in Pfizer’s (NYSE: PFE) executive leadership have been announced this week.

BoardroomPfizerPharmaceuticalUSA

Lophius Biosciences Appoints Dr Robert Phelps as director of business operations

16-12-2013

German biotechnology company Lophius Biosciences GmbH has announced that Dr Robert Phelps has joined…

Antibiotics and Infectious diseasesBiotechnologyBoardroomEuropeImmunologicals

Lundbeck appoints Jacob Tolstrup as senior vice president for Business Development

Lundbeck appoints Jacob Tolstrup as senior vice president for Business Development

16-12-2013

Danish pharmaceutical company H. Lundbeck A/S has appointed Jacob Tolstrup as head of the HR department…

BoardroomDenmarkEuropeH. LundbeckLundbeckNeurologicalPharmaceutical

Genesis 2013: Biotech urged to consider NHS partnering and venture capital

Genesis 2013: Biotech urged to consider NHS partnering and venture capital

16-12-2013

The UK’s brightest bioscience companies met in London for the One Nucleus Genesis 2013 conference on…

BiotechnologyFinancialInterviewsMerck SeronoResearchUK

Teva vice chairman Moshe Many to leave post for 'personal reasons'

Teva vice chairman Moshe Many to leave post for 'personal reasons'

11-12-2013

Israel’s Teva Pharmaceutical Industries announced yesterday that the vice chairman of its board of…

BoardroomGenericsManagementTeva Pharmaceutical Industries

Roche board of directors to be decided at AGM in March

Roche board of directors to be decided at AGM in March

10-12-2013

Swiss drug major Roche (ROG: SIX) has issued a list of members of the Board of Directors to be elected…

BoardroomNorthern EuropePharmaceuticalRoche

Nuevolution appoints Ton Berkien as chief business officer

Nuevolution appoints Ton Berkien as chief business officer

09-12-2013

Denmark-based small molecule lead discovery company Nuevolution A/S has appointed Ton Berkien as Chief…

BoardroomDenmarkEuropeNuevolutionPharmaceutical

ThromboGenics founder Désiré Collen to retire

ThromboGenics founder Désiré Collen to retire

09-12-2013

Belgium-based biopharma firm ThromboGenics (Euronext Brussels: THR: BR) has announced that Désiré Collen…

BelgiumBoardroomEuropePharmaceuticalThromboGenics

Novasep announces Nadege Laborde as new president of its industrial biotech business unit

Novasep announces Nadege Laborde as new president of its industrial biotech business unit

06-12-2013

The France-based biotechnology company Novasep has announced Nadege Laborde as the new president of its…

BiotechnologyBoardroomEuropeNovasep

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

03-12-2013

The UK’s ‘Golden Triangle’ of biotech innovation can compete on the world stage, AstraZeneca (LSE:…

AstraZenecaBoardroomBrilintaInterviewsPharmaceuticalUK

Merck KGaA eighth EPP spin-off to focus on infertility treatment

Merck KGaA eighth EPP spin-off to focus on infertility treatment

02-12-2013

USA-based EMD Serono, one of German drug and chemical group Merck KGaA’s biotechnology subsidiaries,…

BiotechnologyEMD SeronoMerck KGaAMerck SeronoMergers & AcquisitionsReproductiveResearchTocopheRx

Takeda names GSK executive as next chief operating officer

Takeda names GSK executive as next chief operating officer

29-11-2013

Japan’s largest drugmaker, Takeda Pharmaceutical, says that Christophe Weber has been approved at the…

BoardroomManagementPharmaceuticalTakeda Pharmaceuticals

Merck Serono collaborates with Biopharm GmbH on osteoarthritis research

Merck Serono collaborates with Biopharm GmbH on osteoarthritis research

20-11-2013

Privately-held Biopharma GmbH says it has signed an agreement with Merck Serono, the biopharma subsidiary…

Anti-Arthritics/RheumaticsBiopharm GmbHMerck KGaAMerck SeronoPharmaceuticalResearch

Immunologist Yong-Jun Liu named head of research at MedImmune

Immunologist Yong-Jun Liu named head of research at MedImmune

20-11-2013

US-based MedImmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca…

BoardroomImmunologicalsMedImmuneNorth AmericaPharmaceuticalUSA

Jonathan Knowles named as executive chairman of the board of Immunocore and Adaptimmune

Jonathan Knowles named as executive chairman of the board of Immunocore and Adaptimmune

20-11-2013

UK-based biotech company Immunocore has appointed Jonathan Knowles as the new executive chairman of the…

AdaptimmuneBoardroomEuropeImmunocoreOncologyPharmaceuticalUK

Vectura appoints ex-AstraZeneca VP Bruno Angelici as non-executive chairman

Vectura appoints ex-AstraZeneca VP Bruno Angelici as non-executive chairman

20-11-2013

UK-based developer of inhaled therapies Vectura Group (LSE: VEC) has announced the appointment of Bruno…

BoardroomEuropeUKVectura

AmpliPhi Biosciences announces Baxter Phillips as VP of corporate strategy and business development

20-11-2013

US-headquartered biotech company AmpliPhi BioSciences (OTCBB: APHB) has appointed Baxter Phillips III…

AmpliPhi BioSciencesBoardroomNorth AmericaUSA

Affimed Therapeutics appoints Jens-Peter Marschner as chief medical officer

Affimed Therapeutics appoints Jens-Peter Marschner as chief medical officer

20-11-2013

German privately-owned biopharmaceutical company Affimed Therapeutics has appointed Jens-Peter Marschner…

Affimed TherapeuticsBoardroomEuropeMerck KGaA

Interview: Clinigen’s CEO Peter George on the company’s record growth

Interview: Clinigen’s CEO Peter George on the company’s record growth

15-11-2013

If there is one pharma company bucking the trend of shaky financial results it is the Clinigen Group.

BoardroomClinigen GroupFoscavirInterviewsOncologyPharmaceuticalRare diseasesUK

Merck KGaA to invest 80 million euros in China pharma production

Merck KGaA to invest 80 million euros in China pharma production

15-11-2013

Germany’s Merck KGaA said this morning that it plans to invest 80 million euros ($106.8 million) in…

Asia-PacificFinancialMerck KGaAMerck SeronoPharmaceuticalProduction

Raft of senior management changes at Bristol-Myers Squibb

Raft of senior management changes at Bristol-Myers Squibb

14-11-2013

To support its ongoing success as a BioPharma leader, US drug major Bristol-Myers Squibb says it is evolving…

BoardroomBristol-Myers SquibbManagementPharmaceutical

Merck KGaA improves guidance with strong third quarter results

Merck KGaA improves guidance with strong third quarter results

14-11-2013

Germany’s Merck KGaA (MRK: DE) has posted solid organic revenue growth of 4.7% for the third quarter…

BiotechnologyErbituxEuropeFinancialMerck KGaAMerck SeronoPharmaceuticalRebif

73 to 97 of 161 results

Back to top